Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD

Pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 PH, with no current proven targeted therapies. Studies suggest that cigarette smoke, the most risk factor for COPD can cause vascular remodelling and eventually PH as a result of dysfunction and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Abdullah A. Alqarni, Abdulelah M. Aldhahir, Sara A. Alghamdi, Jaber S. Alqahtani, Rayan A. Siraj, Hassan Alwafi, Abdulkareem A. AlGarni, Mansour S. Majrshi, Saad M. Alshehri, Linhua Pang
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2023-10-01
Σειρά:	Frontiers in Medicine
Θέματα:	nitric oxide prostanoid pulmonary hypertension COPD endothelin type 3 pulmonary hypertension
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1275684/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!